Sickle cell vasoocclusion

Heterotypic, multicellular aggregations driven by leukocyte adhesion

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Homozygous expression of sickle β-globin alters the function of blood cells and the endothelium, producing a wide spectrum of clinical manifestations. Intravital microscopy studies in sickle cell mice suggest that vasoocclusion is a complex, sequential, multistep phenomenon involving (1) endothelial activation by sickle erythrocyte (SSRBC), (2) leukocyte (WBC) adhesion to the endothelium, and (3) the direct interaction between SSRBCs and adherent WBCs, which leads to reduced blood flow and tissue ischemia. Each of these steps represents a potentially useful therapeutic target. The identification of molecular determinants mediating vasoocclusion will provide new strategies for the prevention and treatment of this debilitating illness.

Original languageEnglish (US)
Pages (from-to)167-177
Number of pages11
JournalMicrocirculation
Volume11
Issue number2
DOIs
StatePublished - Mar 2004
Externally publishedYes

Fingerprint

Endothelium
Leukocytes
Globins
Blood Cells
Ischemia
Erythrocytes
Therapeutics
Intravital Microscopy

Keywords

  • Endothelial cell
  • Platelet
  • Red blood cell
  • Sickle cell crisis
  • White blood cell

ASJC Scopus subject areas

  • Physiology
  • Genetics
  • Cardiology and Cardiovascular Medicine

Cite this

Sickle cell vasoocclusion : Heterotypic, multicellular aggregations driven by leukocyte adhesion. / Frenette, Paul S.

In: Microcirculation, Vol. 11, No. 2, 03.2004, p. 167-177.

Research output: Contribution to journalArticle

@article{65a83d29e03b4b639ad956472cfa1f99,
title = "Sickle cell vasoocclusion: Heterotypic, multicellular aggregations driven by leukocyte adhesion",
abstract = "Homozygous expression of sickle β-globin alters the function of blood cells and the endothelium, producing a wide spectrum of clinical manifestations. Intravital microscopy studies in sickle cell mice suggest that vasoocclusion is a complex, sequential, multistep phenomenon involving (1) endothelial activation by sickle erythrocyte (SSRBC), (2) leukocyte (WBC) adhesion to the endothelium, and (3) the direct interaction between SSRBCs and adherent WBCs, which leads to reduced blood flow and tissue ischemia. Each of these steps represents a potentially useful therapeutic target. The identification of molecular determinants mediating vasoocclusion will provide new strategies for the prevention and treatment of this debilitating illness.",
keywords = "Endothelial cell, Platelet, Red blood cell, Sickle cell crisis, White blood cell",
author = "Frenette, {Paul S.}",
year = "2004",
month = "3",
doi = "10.1080/10739680490278556",
language = "English (US)",
volume = "11",
pages = "167--177",
journal = "Microcirculation",
issn = "1073-9688",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Sickle cell vasoocclusion

T2 - Heterotypic, multicellular aggregations driven by leukocyte adhesion

AU - Frenette, Paul S.

PY - 2004/3

Y1 - 2004/3

N2 - Homozygous expression of sickle β-globin alters the function of blood cells and the endothelium, producing a wide spectrum of clinical manifestations. Intravital microscopy studies in sickle cell mice suggest that vasoocclusion is a complex, sequential, multistep phenomenon involving (1) endothelial activation by sickle erythrocyte (SSRBC), (2) leukocyte (WBC) adhesion to the endothelium, and (3) the direct interaction between SSRBCs and adherent WBCs, which leads to reduced blood flow and tissue ischemia. Each of these steps represents a potentially useful therapeutic target. The identification of molecular determinants mediating vasoocclusion will provide new strategies for the prevention and treatment of this debilitating illness.

AB - Homozygous expression of sickle β-globin alters the function of blood cells and the endothelium, producing a wide spectrum of clinical manifestations. Intravital microscopy studies in sickle cell mice suggest that vasoocclusion is a complex, sequential, multistep phenomenon involving (1) endothelial activation by sickle erythrocyte (SSRBC), (2) leukocyte (WBC) adhesion to the endothelium, and (3) the direct interaction between SSRBCs and adherent WBCs, which leads to reduced blood flow and tissue ischemia. Each of these steps represents a potentially useful therapeutic target. The identification of molecular determinants mediating vasoocclusion will provide new strategies for the prevention and treatment of this debilitating illness.

KW - Endothelial cell

KW - Platelet

KW - Red blood cell

KW - Sickle cell crisis

KW - White blood cell

UR - http://www.scopus.com/inward/record.url?scp=10244278094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10244278094&partnerID=8YFLogxK

U2 - 10.1080/10739680490278556

DO - 10.1080/10739680490278556

M3 - Article

VL - 11

SP - 167

EP - 177

JO - Microcirculation

JF - Microcirculation

SN - 1073-9688

IS - 2

ER -